Tert-butyl N-[1-[2-[4-(3-bromophenyl)phenyl]-2-(1-hydroxycyclohexyl)acetyl]piperidin-4-yl]carbamate
C30H39BrN2O4 — CID 91249616
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl N-[1-[2-[4-(3-bromophenyl)phenyl]-2-(1-hydroxycyclohexyl)acetyl]piperidin-4-yl]carbamate
Tert-butyl N-[1-[2-[4-(3-bromophenyl)phenyl]-2-(1-hydroxycyclohexyl)acetyl]piperidin-4-yl]carbamate (PubChem CID 91249616) has the molecular formula C30H39BrN2O4 and a molecular weight of 571.56 g/mol. Its IUPAC name is tert-butyl N-[1-[2-[4-(3-bromophenyl)phenyl]-2-(1-hydroxycyclohexyl)acetyl]piperidin-4-yl]carbamate.
Molecular Properties
| Compound Name | Tert-butyl N-[1-[2-[4-(3-bromophenyl)phenyl]-2-(1-hydroxycyclohexyl)acetyl]piperidin-4-yl]carbamate |
|---|---|
| PubChem CID | 91249616 |
| Molecular Formula | C30H39BrN2O4 |
| Molecular Weight | 571.56 g/mol |
| Exact Mass | 570.21 |
| IUPAC Name | tert-butyl N-[1-[2-[4-(3-bromophenyl)phenyl]-2-(1-hydroxycyclohexyl)acetyl]piperidin-4-yl]carbamate |
| SMILES | CC(C)(C)OC(=O)NC1CCN(C(=O)C(c2ccc(-c3cccc(Br)c3)cc2)C2(O)CCCCC2)CC1 |
| InChI | InChI=1S/C30H39BrN2O4/c1-29(2,3)37-28(35)32-25-14-18-33(19-15-25)27(34)26(30(36)16-5-4-6-17-30)22-12-10-21(11-13-22)23-8-7-9-24(31)20-23/h7-13,20,25-26,36H,4-6,14-19H2,1-3H3,(H,32,35) |
| InChIKey | KLQATWSBLXSQTA-UHFFFAOYSA-N |
| XLogP | 6.41 |
| TPSA | 78.87 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 571.56 |
| LogP ≤ 5 | 6.41 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91249616 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.